HYFM is a stock, not an exchange-traded fund, and it does not carry a meaningful, current analyst consensus. TipRanks lists effectively no covering analysts and no 12-month price target, and the single $6.50 figure visible on some aggregators is stale and predates the company's corporate actions. Because no credible aggregate of attributable analyst targets exists, the $1.00 central target here is a fallback objective drawn from public market discussion — a round psychological level that sits near the low end of the limited $0.90–$1.15 target range still appearing on one aggregator. It is not presented as an official analyst consensus.
Hydrofarm Holdings Group, Inc. designs, manufactures, and distributes hydroponics equipment and supplies for controlled environment agriculture, serving growers of cannabis, produce, and other crops across the United States and Canada. The stock has been one of the most distressed names in the space, collapsing from a triple-digit price shortly after its 2020 initial public offering to under $1, and the company completed a 1-for-10 reverse stock split in February 2025 to regain Nasdaq listing compliance.
With shares near $0.77 and a 52-week range of $0.50 to $3.20, a move to $1.00 represents a roughly 30% advance — substantial but not extreme given the stock's extreme volatility. The path would likely depend less on valuation and more on evidence that revenue declines are ending and that the balance sheet can be stabilized. TipRanks data shows trailing revenue contracting, an enterprise value of roughly $155 million dominated by about $158 million of debt, and negative equity, meaning the company's operating turnaround, rather than a re-rating, would have to drive any recovery.
Management has delivered twelve consecutive quarters of year-over-year adjusted SG&A (selling, general, and administrative) savings, a roughly 16% cost reduction in its most recently reported period, and positive free cash flow in that quarter despite a sharp sales decline. A restructuring plan aimed at trimming inventory and SKUs (stock-keeping units) targets more than $3 million in annual savings. A higher proprietary-brand mix and any rebound in hydroponics demand or cannabis-industry sentiment could support sentiment, while the stock's micro-cap float means relatively modest buying interest can produce outsized percentage moves — both upward and downward.
The obstacles are severe. Net sales fell 28.4% year over year to $39.2 million in the company's most recent reported quarter, gross margins remain thin, and the company continues to post significant net losses. Negative shareholders' equity, a debt load far exceeding the equity market value, and reliance on dilutive financing create refinancing and solvency risk. The hydroponics market has been pressured by oversupply and falling crop prices, and competition from larger players such as Scotts Miracle-Gro adds further pressure. Any continued revenue contraction, guidance reduction, or failed Nasdaq listing would weigh heavily on the shares.
The $0.50 area, the 52-week low, is the key support zone below the current price, while $1.00 is both the central target and a clear psychological resistance level. The stock's 52-week high of $3.20 shows how wide its trading range has become, but sustained trading above $1.00 has been elusive since the company's restructuring. Because the float is small and volume is thin, these levels can break quickly in either direction and should be read with caution rather than as precise turning points.
No reliable analyst horizon applies to this name, so the $1.00 objective should be viewed as an open-ended technical and sentiment milestone rather than a dated forecast. Investors should watch quarterly revenue trends, gross margin, free cash flow, and any updates on the restructuring; the next earnings report and any statement on debt, liquidity, or Nasdaq compliance; developments in cannabis and CEA demand; and any further corporate actions such as additional reverse splits or dilutive financings. A sustained break back above the $0.50 support or a confirmed hold above $1.00 would be the clearest signals of direction.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. For a volatile, thinly traded name like HYFM, automated signals can help traders discover opportunities, monitor positions, and spot changing trends more efficiently than manual review. Traders interested in a systematic, data-driven approach can explore these signals as part of their broader research process.
The question of whether Hydrofarm Holdings Group can reach $1.00 hinges on execution, not on an analyst-derived consensus, because meaningful sell-side coverage simply does not exist. Reaching the target would require a roughly 30% advance built on stabilizing revenue, preserved free cash flow, and improved confidence in the balance sheet. Working against that are persistent losses, negative equity, a debt-heavy capital structure, and an oversupplied hydroponics market. The target is best understood as a public-discussion and technical milestone that reflects the low end of the limited target range still circulating, and it should be monitored alongside revenue trends, liquidity, and any changes to the company's capital structure rather than treated as a guaranteed outcome.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, HYFM has been loosely correlated with ACA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if HYFM jumps, then ACA could also see price increases.
| Ticker / NAME | Correlation To HYFM | 1D Price Change % | ||
|---|---|---|---|---|
| HYFM | 100% | +3.63% | ||
| ACA - HYFM | 35% Loosely correlated | N/A | ||
| TEX - HYFM | 22% Poorly correlated | +0.98% | ||
| CMCO - HYFM | 21% Poorly correlated | +7.33% | ||
| WNC - HYFM | 21% Poorly correlated | +3.98% | ||
| ALG - HYFM | 20% Poorly correlated | +1.42% | ||
More | ||||
| Ticker / NAME | Correlation To HYFM | 1D Price Change % |
|---|---|---|
| HYFM | 100% | +3.63% |
| Producer Manufacturing category (346 stocks) | -4% Poorly correlated | +1.04% |